Nasus Pharma is trading 5.54% up at $4.04, with the move appearing primarily sector-driven as Healthcare rises 1.37% alongside a rebound from the prior session’s decline.
- Shares fell 6.34% to $3.83 on September 1.
- No new company-specific announcement dated September 2 was identified in investor-relations news or recent SEC filings; latest notable updates were August 17 financial results and August 19 CFO transition.
- Broader indices are mostly little changed, limiting global support.